EndoTheia
Nashville, US · Tennessee corporation
Endotheia develops next-generation flexible endoscopy technology and products for medical procedures.
BiotechDeep TechHealthtechMedical Devices
Founders & leadership
RJ
Robert J. WebsterExecutive Officer, Director
SD
S. Duke HerrellExecutive Officer, Director
JG
Joshua GaffordExecutive Officer, Director
SW
Scott WebsterExecutive Officer, Director
CR
Caleb RuckerExecutive Officer, Director
SH
Sam HelebaDirector
BH
Brandon HoffmanDirector
Competitors · 2
by search overlapDiabetes Prevention Program6 shared keywords
Boston Scientific4 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Companies competing with EndoTheia for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$500KraisedSep 2024 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedSep 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sam HelebaDirector
- Robert J. WebsterExecutive Officer, Director
- S. Duke HerrellExecutive Officer, Director
- Joshua GaffordExecutive Officer, Director
- Brandon HoffmanDirector
- Scott WebsterExecutive Officer, Director
- Caleb RuckerExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Sep 2024
- Incorporated
- Corporation, Tennessee
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $929.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2019 | $222.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.